Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antifungal medication |
| gptkbp:activeIngredient |
gptkb:amphotericin_B_lipid_complex
|
| gptkbp:approvedBy |
1995
|
| gptkbp:ATCCode |
gptkb:J02AA01
|
| gptkbp:contraindication |
hypersensitivity to amphotericin B
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:form |
lipid complex
|
| gptkbp:halfLife |
5-10 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abelcet
|
| gptkbp:indication |
treatment of candidiasis
treatment of cryptococcal meningitis treatment of invasive aspergillosis treatment of severe systemic fungal infections |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sigma-Tau_Pharmaceuticals
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
fever nausea vomiting chills nephrotoxicity hypotension |
| gptkbp:status |
FDA approved
|
| gptkbp:synonym |
amphotericin B lipid complex injection
|
| gptkbp:bfsParent |
gptkb:amphotericin_B
|
| gptkbp:bfsLayer |
6
|